Cargando…
Evaluation of cognitive functions in a group of Egyptian recovered COVID-19 patients
BACKGROUND: Numerous investigations have found that cognitive deficits in COVID-19 survivors may be reversible; hence, early detection is essential. These cognitive deficiencies should be targeted with scaled cognitive therapies that can be widely used even in patients’ homes, supporting the best po...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200337/ http://dx.doi.org/10.1186/s43045-023-00308-2 |
_version_ | 1785045109487697920 |
---|---|
author | Allam, Hadir E. E. M. Omar, Abd El-Nasser M. Sayed, Maha M. El-Batrawy, Amira N. Mohsen, Nesreen M. Khalifa, Abdel Gawad Ghobrial, Fiby F. |
author_facet | Allam, Hadir E. E. M. Omar, Abd El-Nasser M. Sayed, Maha M. El-Batrawy, Amira N. Mohsen, Nesreen M. Khalifa, Abdel Gawad Ghobrial, Fiby F. |
author_sort | Allam, Hadir E. E. M. |
collection | PubMed |
description | BACKGROUND: Numerous investigations have found that cognitive deficits in COVID-19 survivors may be reversible; hence, early detection is essential. These cognitive deficiencies should be targeted with scaled cognitive therapies that can be widely used even in patients’ homes, supporting the best possible cognitive and functional outcomes. In the meanwhile, it has been observed that COVID-19 patients may experience worry, fear, depression, and other mental health problems. Therefore, subjective cognitive difficulties may be due to emotional discomfort. As a result, these data highlight the significance of early diagnosis of anxiety symptoms and depression symptoms in COVID-19 patients in order to prevent subsequent cognitive problems. All patients were selected in accordance with the case definition and used the following tools after 1, 3, and 6 months after being cleared of COVID-19 infection: developed questionnaire for both clinical and demographic data, the Wisconsin Card Sorting Test, the Wechsler Memory Scale-Revised, the Wechsler Adult Intelligence Scale, the Hamilton Anxiety Rating Scale, the Beck Depression Inventory, and Structured Clinical Interview for DSM-IV disorders. RESULTS: Fifty patients were participated in this study from both gender, different levels of education, and the major group was nonsmokers (82%). A total of 88% of participants had confirmed COVID-19, and 12% had contact with them. Wisconsin Card Sorting Test for preservative parameters revealed that the 2nd follow-up showed nonsignificant comparison to the 1st follow-up, while the 3rd showed highly significant comparison to the 1st follow-up. While for non-preservative errors, the 2nd follow-up showed significant comparison to the 1st, while the 3rd showed highly significant comparison to the 1st follow-up. Conceptual level response parameters showed that both the 2nd and the 3rd follow-ups showed nonsignificant comparison to the 1st follow-up. There was no significant correlation between Hamilton Anxiety Scale (HAS) and any parameter of Wisconsin Card Sorting Test or any parameter of Wechsler Memory Scale-Revised. CONCLUSIONS: While there was negative impact of COVID-19 infection on cognitive functions in Egyptian recovered COVID-19 patients which improves gradually by time, there was nonsignificant correlations between anxiety symptoms, depressive symptoms, and Wisconsin Card Sorting Test as well as Wechsler Memory Scale-Revised parameters in tested individuals through three consecutive follow-ups of COVID-19 in Egypt. Further testing using other scales or larger sample is mandatory to elucidate further potential impact of COVID-19 on cognitive functions of recovered patients. |
format | Online Article Text |
id | pubmed-10200337 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-102003372023-05-23 Evaluation of cognitive functions in a group of Egyptian recovered COVID-19 patients Allam, Hadir E. E. M. Omar, Abd El-Nasser M. Sayed, Maha M. El-Batrawy, Amira N. Mohsen, Nesreen M. Khalifa, Abdel Gawad Ghobrial, Fiby F. Middle East Curr Psychiatry Research BACKGROUND: Numerous investigations have found that cognitive deficits in COVID-19 survivors may be reversible; hence, early detection is essential. These cognitive deficiencies should be targeted with scaled cognitive therapies that can be widely used even in patients’ homes, supporting the best possible cognitive and functional outcomes. In the meanwhile, it has been observed that COVID-19 patients may experience worry, fear, depression, and other mental health problems. Therefore, subjective cognitive difficulties may be due to emotional discomfort. As a result, these data highlight the significance of early diagnosis of anxiety symptoms and depression symptoms in COVID-19 patients in order to prevent subsequent cognitive problems. All patients were selected in accordance with the case definition and used the following tools after 1, 3, and 6 months after being cleared of COVID-19 infection: developed questionnaire for both clinical and demographic data, the Wisconsin Card Sorting Test, the Wechsler Memory Scale-Revised, the Wechsler Adult Intelligence Scale, the Hamilton Anxiety Rating Scale, the Beck Depression Inventory, and Structured Clinical Interview for DSM-IV disorders. RESULTS: Fifty patients were participated in this study from both gender, different levels of education, and the major group was nonsmokers (82%). A total of 88% of participants had confirmed COVID-19, and 12% had contact with them. Wisconsin Card Sorting Test for preservative parameters revealed that the 2nd follow-up showed nonsignificant comparison to the 1st follow-up, while the 3rd showed highly significant comparison to the 1st follow-up. While for non-preservative errors, the 2nd follow-up showed significant comparison to the 1st, while the 3rd showed highly significant comparison to the 1st follow-up. Conceptual level response parameters showed that both the 2nd and the 3rd follow-ups showed nonsignificant comparison to the 1st follow-up. There was no significant correlation between Hamilton Anxiety Scale (HAS) and any parameter of Wisconsin Card Sorting Test or any parameter of Wechsler Memory Scale-Revised. CONCLUSIONS: While there was negative impact of COVID-19 infection on cognitive functions in Egyptian recovered COVID-19 patients which improves gradually by time, there was nonsignificant correlations between anxiety symptoms, depressive symptoms, and Wisconsin Card Sorting Test as well as Wechsler Memory Scale-Revised parameters in tested individuals through three consecutive follow-ups of COVID-19 in Egypt. Further testing using other scales or larger sample is mandatory to elucidate further potential impact of COVID-19 on cognitive functions of recovered patients. Springer Berlin Heidelberg 2023-05-22 2023 /pmc/articles/PMC10200337/ http://dx.doi.org/10.1186/s43045-023-00308-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Allam, Hadir E. E. M. Omar, Abd El-Nasser M. Sayed, Maha M. El-Batrawy, Amira N. Mohsen, Nesreen M. Khalifa, Abdel Gawad Ghobrial, Fiby F. Evaluation of cognitive functions in a group of Egyptian recovered COVID-19 patients |
title | Evaluation of cognitive functions in a group of Egyptian recovered COVID-19 patients |
title_full | Evaluation of cognitive functions in a group of Egyptian recovered COVID-19 patients |
title_fullStr | Evaluation of cognitive functions in a group of Egyptian recovered COVID-19 patients |
title_full_unstemmed | Evaluation of cognitive functions in a group of Egyptian recovered COVID-19 patients |
title_short | Evaluation of cognitive functions in a group of Egyptian recovered COVID-19 patients |
title_sort | evaluation of cognitive functions in a group of egyptian recovered covid-19 patients |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200337/ http://dx.doi.org/10.1186/s43045-023-00308-2 |
work_keys_str_mv | AT allamhadireem evaluationofcognitivefunctionsinagroupofegyptianrecoveredcovid19patients AT omarabdelnasserm evaluationofcognitivefunctionsinagroupofegyptianrecoveredcovid19patients AT sayedmaham evaluationofcognitivefunctionsinagroupofegyptianrecoveredcovid19patients AT elbatrawyamiran evaluationofcognitivefunctionsinagroupofegyptianrecoveredcovid19patients AT mohsennesreenm evaluationofcognitivefunctionsinagroupofegyptianrecoveredcovid19patients AT khalifaabdelgawad evaluationofcognitivefunctionsinagroupofegyptianrecoveredcovid19patients AT ghobrialfibyf evaluationofcognitivefunctionsinagroupofegyptianrecoveredcovid19patients |